Mutation in the pleckstrin homology domain of the human phospholipase C-delta 1 gene is associated with loss of function. 1998

S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
Department of Neurology, Faculty of Medicine, Kyoto University, Japan. i53367@sakura.kudpc.kyoto-u.ac.jp

The delta-type phospholipase C (PLC) is thought to be evolutionally the most basal form in the mammalian PLC family. One of the delta-type isoforms, PLC-delta 1, binds to both phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) with a high affinity via its pleckstrin homology (PH) domain. We report here a missense mutation in the region encoding the C-terminal PH domain of the human PLC-delta 1. This is also the first report of a mutation in the human PLC genes. A single base substitution (G to A) causes the amino acid replacement, Arg105 to His. Site-directed mutagenesis of the glutathione-S-transferase (GST)/PLC-delta 1 fusion protein changing Arg105 to His resulted in a fourfold decrease in the affinity of specific Ins(1,4,5)P3 binding and a reduction in PtdIns(4,5)P2 hydrolysing activity to about 40% of that of the wild-type enzyme. This remarkable loss of function can be interpreted in terms of a conformational change in the PH domain.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D010750 Phosphoproteins Phosphoprotein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
December 1995, The Biochemical journal,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
December 1995, Biochemistry,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
June 2013, Biochimica et biophysica acta,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
July 2005, The Biochemical journal,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
December 2007, Protein expression and purification,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
January 2007, The FEBS journal,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
May 2002, The Journal of biological chemistry,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
July 1996, Biochemical and biophysical research communications,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
December 2012, Analytical biochemistry,
S Shimohama, and S Kamiya, and M Fujii, and T Ogawa, and M Kanamori, and J Kawamata, and T Imura, and T Taniguchi, and H Yagisawa
June 2003, The Journal of biological chemistry,
Copied contents to your clipboard!